AVACEN Medical
[Closed for Investment] AVACEN Medical, with a valuation of $75.9 million, is raising funds on StartEngine. The company provides non-invasive and FDA-cleared pain relief and wellness devices and diagnostics for cardiovascular diseases and stress. The medical devices of AVACEN Medical use a thermotherapy platform technology to increase blood flow to the blood vessels and reduce pain. AVACEN Medical has sold over 9,000 devices and provides 22 million treatments without adverse effects. Anthony Shimkin, Thomas Muehlbauer, and Danielle Forsgren founded AVACEN Medical in September 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1.24 million. The campaign proceeds will be used for clinical studies, research and development, marketing, company employment, and working capital.
Investment Overview
Raised: $286,056
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 06/23/2023
- Close Date
- 10/11/2023
$10,000
$1,235,000
$500
Equity - Common
Seed
RegCF
$1.00
$75,904,940
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2C
- Margin
- Medium
- Capital Intensity
- High
Financials
- Revenue +5% YoY
- $4,814,854
- Monthly Burn
- Profitable
- Cash on Hand
- $257,171
- Gross Margin
- 59%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $4,000,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 10/11/2023 | StartEngine | $75,904,940 | $286,056 | Equity - Common | Funded | RegCF |